GB877306A - Halogenated derivatives of tetrahydro-1-naphthyl cyclic amidines - Google Patents
Halogenated derivatives of tetrahydro-1-naphthyl cyclic amidinesInfo
- Publication number
- GB877306A GB877306A GB12594/59A GB1259459A GB877306A GB 877306 A GB877306 A GB 877306A GB 12594/59 A GB12594/59 A GB 12594/59A GB 1259459 A GB1259459 A GB 1259459A GB 877306 A GB877306 A GB 877306A
- Authority
- GB
- United Kingdom
- Prior art keywords
- halogenated
- tetrahydro
- produce
- acid
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention comprises compounds of the formula <FORM:0877306/IV (b)/1> wherein X represents at least one halogen atom, R is a hydrogen atom or a C1-C5 alkyl or C2-C5 alkenyl radical, and n is 2 or 3, and acid addition salts thereof, and the preparation thereof by alcoholysing a halogenatedphenylacetonitrile to an alkyl halogenated-phenylacetate and adding an alkyl acrylate to produce a dialkyl alpha-(halogenated-phenyl)-glutarate and hydrolysing the glutarate to produce an alpha-(halogenated-phenyl)-glutaric acid and dehydrating the acid to produce an alpha-(halogenated-phenyl)-glutaric anhydride and cyclizing this to a halogenated-4-keto 1,2,3,4-tetrahydro-1-naphthoic acid and reducing this to a halogenated-1,2,3,4-tetrahydro-1-naphthoic acid and amidating this to a halogenated - 1,2,3,4 - tetrahydro - 1 - naphthoamide and dehydrating the amide to produce a halogenated 1,2,3,4-tetrahydro-1-naphthonitrile and condensing the nitrile with an unsubstituted or mono-N-substituted ethylene diamine or 1,3-diaminopropane; and, if desired, converting the products into their acid addition salts. The products have depressor, blood pressure lowering, adrenergic blocking or cardiac rate decreasing properties depending upon their molecular structures. o-Chlorophenyl-acetonitrile and o-bromophenyl-acetonitrile are prepared by treating the corresponding o-halogenobenzyl halides with potassium cyanide.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US877306XA | 1958-04-21 | 1958-04-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB877306A true GB877306A (en) | 1961-09-13 |
Family
ID=22206915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB12594/59A Expired GB877306A (en) | 1958-04-21 | 1959-04-14 | Halogenated derivatives of tetrahydro-1-naphthyl cyclic amidines |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB877306A (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2312244A1 (en) * | 1975-05-30 | 1976-12-24 | Scherico Ltd | Hypoglycaemic 2-imidazolines - e.g. (2-(6-fluoro 1,2,3,4-tetrahydro 1-naphthyl methyl) imidazoline |
US4002626A (en) * | 1976-03-15 | 1977-01-11 | Morton-Norwich Products, Inc. | 1-(2-Naphthylmethyl)-3,4,5,6-tetrahydro-2(1H)pyrimidone |
US4634705A (en) * | 1984-06-06 | 1987-01-06 | Abbott Laboratories | Adrenergic amidines |
WO2007085558A1 (en) * | 2006-01-27 | 2007-08-02 | F. Hoffmann-La Roche Ag | Use of 2-imidazoles for the treatment of cns disorders |
US7652055B2 (en) | 2007-07-02 | 2010-01-26 | Hoffman-La Roche Inc. | 2-imidazolines |
US7812047B2 (en) | 2007-07-03 | 2010-10-12 | Hoffman-La Roche Inc. | 4-imidazolines |
US7834044B2 (en) | 2006-11-02 | 2010-11-16 | Hoffman-Laroche Inc. | Substituted-2-imidazoles |
US7858652B2 (en) | 2006-11-16 | 2010-12-28 | Hoffmann-La Roche Inc. | Substituted 4-imidazoles |
US7858653B2 (en) | 2006-12-13 | 2010-12-28 | Hoffman-La Roche Inc. | 2-imidazoles |
US7902238B2 (en) | 2007-02-15 | 2011-03-08 | Hoffmann-La Roche Inc. | 2-aminooxazolines as TAAR1 ligands |
US8008305B2 (en) | 2007-08-03 | 2011-08-30 | Hoffmann-La Roche Inc. | TAAR1 ligands |
US8242153B2 (en) | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
US8354441B2 (en) | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
US8389507B2 (en) | 2007-07-27 | 2013-03-05 | Hoffmann-La Roche Inc. | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands |
US8399463B2 (en) | 2006-12-18 | 2013-03-19 | Hoffmann-La Roche Inc. | Imidazole derivatives |
US8586617B2 (en) | 2006-10-19 | 2013-11-19 | Hoffmann-La Roche Inc. | Aminomethyl-4-imidazoles |
US8604061B2 (en) | 2007-02-02 | 2013-12-10 | Hoffmann-La Roche Inc. | 2-aminooxazolines as TAAR1 ligands |
US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
US10508107B2 (en) | 2016-03-17 | 2019-12-17 | Hoffmann-La Roche Inc. | Morpholine derivative |
-
1959
- 1959-04-14 GB GB12594/59A patent/GB877306A/en not_active Expired
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2312244A1 (en) * | 1975-05-30 | 1976-12-24 | Scherico Ltd | Hypoglycaemic 2-imidazolines - e.g. (2-(6-fluoro 1,2,3,4-tetrahydro 1-naphthyl methyl) imidazoline |
US4002626A (en) * | 1976-03-15 | 1977-01-11 | Morton-Norwich Products, Inc. | 1-(2-Naphthylmethyl)-3,4,5,6-tetrahydro-2(1H)pyrimidone |
US4634705A (en) * | 1984-06-06 | 1987-01-06 | Abbott Laboratories | Adrenergic amidines |
WO2007085558A1 (en) * | 2006-01-27 | 2007-08-02 | F. Hoffmann-La Roche Ag | Use of 2-imidazoles for the treatment of cns disorders |
US8586617B2 (en) | 2006-10-19 | 2013-11-19 | Hoffmann-La Roche Inc. | Aminomethyl-4-imidazoles |
US7834044B2 (en) | 2006-11-02 | 2010-11-16 | Hoffman-Laroche Inc. | Substituted-2-imidazoles |
US7858652B2 (en) | 2006-11-16 | 2010-12-28 | Hoffmann-La Roche Inc. | Substituted 4-imidazoles |
US7858653B2 (en) | 2006-12-13 | 2010-12-28 | Hoffman-La Roche Inc. | 2-imidazoles |
US8399463B2 (en) | 2006-12-18 | 2013-03-19 | Hoffmann-La Roche Inc. | Imidazole derivatives |
US8604061B2 (en) | 2007-02-02 | 2013-12-10 | Hoffmann-La Roche Inc. | 2-aminooxazolines as TAAR1 ligands |
US7902238B2 (en) | 2007-02-15 | 2011-03-08 | Hoffmann-La Roche Inc. | 2-aminooxazolines as TAAR1 ligands |
US7652055B2 (en) | 2007-07-02 | 2010-01-26 | Hoffman-La Roche Inc. | 2-imidazolines |
US7812047B2 (en) | 2007-07-03 | 2010-10-12 | Hoffman-La Roche Inc. | 4-imidazolines |
US8389507B2 (en) | 2007-07-27 | 2013-03-05 | Hoffmann-La Roche Inc. | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands |
US8008305B2 (en) | 2007-08-03 | 2011-08-30 | Hoffmann-La Roche Inc. | TAAR1 ligands |
US8242153B2 (en) | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
US8729113B2 (en) | 2008-07-24 | 2014-05-20 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2yl derivatives |
US8354441B2 (en) | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
US10508107B2 (en) | 2016-03-17 | 2019-12-17 | Hoffmann-La Roche Inc. | Morpholine derivative |
US11312711B2 (en) | 2016-03-17 | 2022-04-26 | Hoffmann-La Roche Inc. | Morpholine derivative |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB877306A (en) | Halogenated derivatives of tetrahydro-1-naphthyl cyclic amidines | |
ES316768A1 (en) | Procedure for the preparation of a new polyamide. (Machine-translation by Google Translate, not legally binding) | |
GB1058332A (en) | Improvements in or relating to the preparation of maleamic acid derivatives | |
GB967718A (en) | N-substituted azaspiranes | |
GB921078A (en) | A process for the preparation of alpha-halo-omega-lactones | |
ES265993A1 (en) | Disinfectant and anti-inflammatory composition and method of using same | |
GB925612A (en) | Process for stabilising aromatic polymers | |
GB1292787A (en) | Benzodioxane derivatives and pharmaceutical compositions containing them | |
GB959420A (en) | Oxyalkylated carboxylic acid amides and production thereof | |
GB1126994A (en) | Guanidine derivatives and processes for preparing the same | |
GB1344501A (en) | Ampholytic carboxylated fluorinated compounds | |
GB980251A (en) | New piperazine derivatives | |
GB1305725A (en) | ||
GB932531A (en) | Substituted amides | |
GB1002856A (en) | Pyrrolidine derivatives | |
GB913716A (en) | Sulphonamides | |
GB1317080A (en) | Preparation of o-chlorophenols | |
GB1102807A (en) | Benzothiazine derivatives and their preparation | |
GB980878A (en) | Condensation products of tetracyclines, preparations containing them and process of preparing them | |
GB926624A (en) | New amines and process for their manufacture | |
GB870888A (en) | Substituted piperazinone | |
GB1014919A (en) | Acetamide derivatives and process for their preparation | |
GB1289918A (en) | ||
JPS5233673A (en) | Hydrantoin fungcides for agricultural and gardening use | |
GB1033909A (en) | Anticoccidial compositions |